Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycythemia Vera 11 Brain Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 9 Leukemia, Myeloid, Chronic-Phase 9 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9 Leukemia 9 Glioblastoma 9 Leukemia, Myeloid, Acute 8 Meningioma 7 Head and Neck Neoplasms 7 Gliosarcoma 6 Myelodysplastic Syndromes 4 Glioma 4 Central Nervous System Neoplasms 4 Neoplasms 3 Myeloproliferative Disorders 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3 Laryngeal Neoplasms 3 Esophageal Neoplasms 3 Treatment-Refractory Solid Tumors 2 Thrombocythemia, Essential 2 Stomach Neoplasms 2 Salivary Gland Neoplasms 2 Primary Myelofibrosis 2 Pharyngeal Neoplasms 2 Paranasal Sinus Neoplasms 2 Oropharyngeal Neoplasms 2 Myelodysplastic-Myeloproliferative Diseases 2 Hypopharyngeal Neoplasms 2

Interventions

Imatinib Mesylate 2 telapristone acetate 1 seclidemstat 1 Uterine Myomectomy 1 Triamcinolone Acetonide 1 Topotecan 1 Specimen Handling 1 Sodium Chloride 1 Sirolimus 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Hydroxyurea 1 Cyclophosphamide 1 CTLA-4 Antigen 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Fibroma × Hydroxyurea × Clear all

NCT00978146 2017-04-20

Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors

Children's Hospital of Philadelphia

Phase 2 Withdrawn

Fibroma, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡